N-[3-(Benzimidazol-1-yl)-1,4-dioxonaphthalen-2-yl]-4-nitrobenzenesulfonamide is a synthetic organic compound characterized by its complex structure, which includes a benzimidazole moiety, a naphthalene derivative, and a sulfonamide group. This compound typically exhibits properties such as high stability under standard conditions and solubility in polar organic solvents, which is common for sulfonamide derivatives. Its molecular structure suggests potential biological activity, particularly in medicinal chemistry, where such compounds are often investigated for their antibacterial or anticancer properties. The presence of the nitro group may enhance its reactivity and biological interactions. Additionally, the dioxo and sulfonamide functionalities can contribute to its pharmacological profile, making it a candidate for further research in drug development. As with many synthetic compounds, safety and handling precautions are essential due to potential toxicity or reactivity. Overall, this compound represents a class of molecules with significant interest in both academic and pharmaceutical research.

AUTEN-67 is an autophagy enhancer and specific inhibitor of MTMR14 with potent antiaging and neuroprotective effects. It also delays the onset and decreases the severity of Huntington's disease.

N-[3-(benzimidazol-1-yl)-1,4-dioxonaphthalen-2-yl]-4-nitrobenzenesulfonamide

301154-74-5: N-[3-(Benzimidazol-1-yl)-1,4-dioxonaphthalen-2-yl]-4-nitrobenzenesulfonamide is a synthetic organic compound characterized by its complex structure, which includes a benzimidazole moiety, a naphthalene derivative, and a sulfonamide group. This compound typically exhibits properties such as high stability under standard conditions and solubility in polar organic solvents, which is common for sulfonamide derivatives. Its molecular structure suggests potential biological activity, particularly in medicinal chemistry, where such compounds are often investigated for their antibacterial or anticancer properties. The presence of the nitro group may enhance its reactivity and biological interactions. Additionally, the dioxo and sulfonamide functionalities can contribute to its pharmacological profile, making it a candidate for further research in drug development. As with many synthetic compounds, safety and handling precautions are essential due to potential toxicity or reactivity. Overall, this compound represents a class of molecules with significant interest in both academic and pharmaceutical research.

<p>AUTEN-67 inhibits MTMR14, boosts autophagy, has antiaging/neuroprotective properties, and combats Huntington's disease onset/severity.</p>

CAS 301154-74-5

N-[3-(benzimidazol-1-yl)-1,4-dioxonaphthalen-2-yl]-4-nitrobenzenesulfonamide

AUTEN-67

Ref: TM-T26683